Kanako C Hatanaka

6PUBLICATIONS
69CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMedical molecular engineering of nucleic acids and proteinsGene expression (incl. microarray and other genome-wide approaches)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 29, 2026
Feasibility study of photoimmunotherapy combination with ASP-1929 for vulvar, vaginal, and cervical cancer.

|May 22, 2026
Hokkaido phase II study of photo-immunotherapy combination with ASP-1929 for recurrent or persistent EGFR-positive vulvar, vaginal, and cervical cancers not amenable to further radiotherapy (HICARi study).

|Jan 21, 2026
HER2 Protein Overexpression, mRNA Expression, and DNA Amplification Across Solid Tumors: Comparison of Next-Generation Sequencing-Based Assays With Immunohistochemistry.

Michiko Nagamine, Takao Fujisawa, Naoya Sakamoto

|Jan 17, 2025
Actionable Gene Alterations Identified in Patients With Malignant Melanoma by Targeted Sequencing in Japan.

Takuro Noguchi, Shin Ariga, Rika Moku

|Jun 19, 2024
Evaluating Cellularity Estimation Methods: Comparing AI Counting with Pathologists' Visual Estimates.

Tomoharu Kiyuna, Eric Cosatto, Kanako C Hatanaka

|Jun 28, 2023
Drosophila Screening Identifies Dual Inhibition of MEK and AURKB as an Effective Therapy for Pancreatic Ductal Adenocarcinoma.

Sho Sekiya, Junki Fukuda, Ryodai Yamamura

Pageof 1

Frequent Collaborators

6 joint publications

Yutaka Hatanaka

3 joint publications

Michiko Nagamine

2 joint publications

Hiroko Matsumiya

2 joint publications

Yuko Sasajima